Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease worldwide, and its incidence is increasing annually, but there is currently no specific drug for treating NAFLD. Shenling Baizhu powder (SL) is a safe herbal compound commonly used in clinical practice. Our previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Kairui, Deng, Yuanjun, Zheng, Chuiyang, Nie, Huan, Pan, Maoxing, Chen, Runsen, Xie, Jiqian, Yang, Qinhe, Zhang, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533788/
https://www.ncbi.nlm.nih.gov/pubmed/33062150
http://dx.doi.org/10.1155/2020/9701285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533788/
https://www.ncbi.nlm.nih.gov/pubmed/33062150
http://dx.doi.org/10.1155/2020/9701285

Ejemplares similares